A report from Goldman Sachs reiterates its Neutral rating on D.R. Horton DHI.
The report states, “The majority of DR Horton's 4QFY11 results were in line; however, the EPS miss was driven primarily by a 70 bp margin shortfall. One offsetting positive is the minimal 4Q writedowns for a company that has historically taken much larger seasonal impairments. We believe that most builders are at the end of their inventory writedown cycle, absent a major step down in home prices.”
DHI closed yesterday at $11.66.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in